本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

151.83
+2.331.56%
盤後151.830.00000.00%19:30 EDT
成交量:117.83萬
成交額:1.78億
市值:154.87億
市盈率:22.25
高:152.07
開:151.14
低:149.71
收:149.50
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:1.20
換手率:1.18%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.19
市盈率(LYR):32.51

資料載入中...

2024/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/01

重要事件披露

Form 8-K - Current report
2024/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities